Trial · NCT02914561
Participant flow88
How many started, completed or left each group, period by period.
1 to 20 of 88
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Induction Study (Day 1 to Week 10) | STARTED | Cohort A: Filgotinib 200 mg (Induction Study) | 223 | |
| Induction Study (Day 1 to Week 10) | STARTED | Cohort A: Filgotinib 100 mg (Induction Study) | 245 | |
| Induction Study (Day 1 to Week 10) | STARTED | Cohort A: Placebo (Induction Study) | 239 | |
| Induction Study (Day 1 to Week 10) | STARTED | Cohort B: Filgotinib 200 mg (Induction Study) | 204 | |
| Induction Study (Day 1 to Week 10) | STARTED | Cohort B: Filgotinib 100 mg (Induction Study) | 230 | |
| Induction Study (Day 1 to Week 10) | STARTED | Cohort B: Placebo (Induction Study) | 231 | |
| Induction Study (Day 1 to Week 10) | STARTED | Filgotinib 200 mg to Filgotinib 200 mg (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | STARTED | Filgotinib 200 mg to Placebo (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | STARTED | Filgotinib 100 mg to Filgotinib 100 mg (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | STARTED | Filgotinib 100 mg to Placebo (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | STARTED | Placebo to Placebo (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort A: Filgotinib 200 mg (Induction Study) | 222 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort A: Filgotinib 100 mg (Induction Study) | 245 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort A: Placebo (Induction Study) | 237 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort B: Filgotinib 200 mg (Induction Study) | 202 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort B: Filgotinib 100 mg (Induction Study) | 228 | |
| Induction Study (Day 1 to Week 10) | Treated | Cohort B: Placebo (Induction Study) | 229 | |
| Induction Study (Day 1 to Week 10) | Treated | Filgotinib 200 mg to Filgotinib 200 mg (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | Treated | Filgotinib 200 mg to Placebo (Maintenance Study) | 0 | |
| Induction Study (Day 1 to Week 10) | Treated | Filgotinib 100 mg to Filgotinib 100 mg (Maintenance Study) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02914561/flow